Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma…
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising…
Compared with patients receiving hormone therapy alone, patients were nine times more likely to have little to no cancer remaining…
May 31, 2026 06:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions31 May 2026 at 13:00 EESTNokia Corporation - Managers'…
MONACO, May 30, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after the project announced that its…
New York City, NY, May 30, 2026 (GLOBE NEWSWIRE) -- The global men’s wellness industry continues to grow rapidly, driven…
Exploratory analysis showed favorable patient-reported quality of life outcomes and delayed time to deterioration in patients receiving ¹⁷⁷Lu-edotreotideData build upon…
– Post hoc analysis from pivotal Launch-HTN trial shows statistically significant and clinically meaningful reductions in blood pressure in participants…
– Updated data across two dose levels of 200 mW/cm and 400 mW/cm in LA-PDAC trial show 71% (5/7) patients…
May 29, 2026 21:18 ET | Source: Fobi AI Inc. VANCOUVER, BC, May 29, 2026 (GLOBE NEWSWIRE) -- Fobi” or…